PSMA-positive Secondary Tumors in 68Ga-PSMA PET/CT Imaging in Patients with Prostate Cancer.

SS Karyağar - European Archives of Medical Research, 2020 - search.ebscohost.com
Objective: The objective of this research was to examine the prostate-specific membrane
antigen (PSMA)-positive secondary tumor incidence in 68Ga-PSMA positron emission …

New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography

A Afaq, D Batura, J Bomanji - International urology and nephrology, 2017 - Springer
Prostate-specific membrane antigen positron emission tomography (PSMA PET) is a
relatively new method of imaging prostate cancer that increases diagnostic accuracy in …

Orbital Hemangiopericytoma in 68Ga–prostate-specific membrane antigen–HBED–CC PET/CT

J Hammes, C Kobe, U Hilgenberg, WE Lieb… - Clinical Nuclear …, 2017 - journals.lww.com
A 76-year-old man with biochemical relapse of prostate cancer underwent 68 Ga–prostate-
specific membrane antigen PET/CT. Besides a local lymph node metastasis, a nodular …

68Ga-PSMA PET/CT imaging and 153Sm-EDTMP bone pain palliation therapy

A Sasikumar, A Joy, R Nanabala… - Clinical Nuclear …, 2016 - journals.lww.com
Abstract 68 Ga-labeled prostate-specific membrane antigen (PSMA) is a potential tool in the
imaging of recurrent prostate cancer. 68 Ga-PSMA imaging is also useful for radiotherapy …

正电子核素68Ga标记PSMA靶向分子探针在神经胶质瘤模型中的应用

韩雪迪, 刘菲, 郭晓轶, 徐晓霞, 解清华, 刘特立, 朱华… - 肿瘤防治研究, 2018 - zlfzyj.com
正电子核素68Ga标记PSMA靶向分子探针在神经胶质瘤模型中的应用韩雪迪, 刘菲, 郭晓轶,
徐晓霞, 解 Page 1 正电子核素68Ga标记PSMA靶向分子探针在神经胶质瘤模型中的应用 …

68Ga-PSMA PET/CT: Normal Variants, Pitfalls and Artefacts

K Agrawal, S Usmani, A Esmail, F Marafi… - PET/CT Imaging: Basics …, 2022 - Springer
Prostate-specific membrane antigen (PSMA) is a transmembrane protein expressed in all
types of prostatic tissue, including carcinoma. High expression of PSMA in prostate …

Prostate cancer theranostics using GRPR antagonist RM26

B Mitran - 2019 - diva-portal.org
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 274. 80
pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0695-7. The malignant …

177Lu-DOTA-HYNIC-iPSMA as a therapeutic radiopharmaceutical targeting prostate-specific membrane antigen

GF FLORES, BEO GARCÍA, MAL GUTIÉRREZ… - 2019 - Google Patents
Esta invención se refiere a un nuevo radiofármaco terapéutico de lutecio-177 como
inhibidor del antígeno prostático específico de membrana (iPSMA), donde el ácido 1, 4, 7 …

Kanhaiyalal Agrawal, Sharjeel Usmani, Abdulredha Esmail

F Marafi, G Gnanasegaran - PET/CT Imaging: Basics and …, 2021 - books.google.com
Prostate-specific membrane antigen (PSMA), a type II transmembrane protein expressed in
all types of prostatic tissue, including benign secretory acinar epithelium, high grade …

[PDF][PDF] PET-CT COM PSMA-GA68 NO CÂNCER DE MAMA TRIPLO NEGATIVO METASTÁTICO

R de Almeida, VV Berto, MV Paschoal… - Journal of Medical …, 2022 - ids.med.br
Objetivos: O câncer de mama triplo negativo carece de marcadores e tratamentos-alvo
específicos. Nesse contexto, o objetivo deste trabalho foi avaliar, por meio de estudos de …